局部镇痛药市场：按药物类别、剂型、治疗用途、疼痛类型、分布、药物类型、药物配方、性别、年龄层、分销管道和地区划分

局部止痛药市场规模预计在 2025 年达到 121 亿美元，预计到 2032 年将达到 185.6 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.3%。

全球局部止痛药市场是疼痛管理製药行业的一个重要组成部分，涵盖了各种用于局部缓解各种疼痛状况的局部治疗产品。局部止痛药包括乳膏、凝胶、贴片、喷雾和软膏，它们透过经皮吸收将活性药物成分直接输送到患处，在提供靶向疼痛缓解的同时，最大限度地减少全身暴露和相关副作用。该市场涉及多种治疗用途，用于治疗急性和慢性疼痛状况，包括关节炎、肌肉拉伤、下背痛、神经病变疼痛和运动相关损伤。肌肉骨骼疾病的盛行率不断上升、人口老化以及消费者对非侵入性疼痛管理替代方案的日益增长的偏好，这些都对市场扩张做出了重大贡献。推动市场成长的关键活性成分包括薄荷醇、辣椒素、水杨酸盐、非类固醇消炎剂和Lidocaine，每种成分都有不同的镇痛作用机制。市场提供处方药和非处方药，以满足多样化的消费者需求和医疗保健提供者的偏好。经皮贴片和奈米製剂等药物传递系统的技术进步正在提高产品功效和患者依从性，进一步刺激市场发展，并为创新治疗解决方案创造机会。

市场动态

全球局部止痛药市场主要受若干相互关联的因素驱动，这些因素支撑着市场的持续成长和扩张。全球人口老化以及关节炎、纤维肌痛和神经病变疼痛等慢性疼痛疾病的盛行率不断上升，导致对有效的局部疼痛管理解决方案的需求庞大。人们日益意识到口服止痛药的副作用，包括胃肠道併发症和依赖性风险，这促使消费者和医疗保健提供偏好转向能够减少全身暴露并提供局部缓解的局部用药。体育和健身文化的扩展以及随之而来的体育活动参与度的提高，导致对用于治疗运动相关损伤和肌肉疲劳的局部止痛药的需求持续增长。然而，市场面临着可能阻碍其成长轨迹的重大限制。对新产品核可（尤其是处方笺药）审批的严格监管要求，设定了市场进入门槛，并增加了製药公司的开发成本。局部製剂有限的渗透深度限制了其对深部疼痛的有效性，从而可能限制市场覆盖范围和消费者的接受度。消费者对价格的高度敏感，尤其是在新兴市场，为高价位的创新产品带来了挑战。然而，市场格局也蕴藏着巨大的机会。先进药物传输技术（例如基于奈米技术的製剂和渗透增强系统）的发展，为提升疗效和拓展应用领域提供了机会。对天然和有机止痛药日益增长的需求，为植物来源製剂和洁净标示替代品创造了一个利基市场。亚太和拉丁美洲的新兴市场由于医疗保健支出的增加、疼痛管理意识的增强以及购买力强劲的中产阶级人口的不断壮大，展现出巨大的增长潜力。

本次调查的主要特点

• 本报告对全球局部镇痛药市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
• 它还揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球局部止痛药市场的主要企业。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员将透过用于分析全球局部止痛药市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章：调查目标和先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020 年至 2032 年全球局部止痛药市场（依药物分类）

• 非鸦片类局部止痛药
• 阿片类局部镇痛药

5. 2020-2032 年全球局部止痛药市场（以剂型划分）

• 奶油
• 凝胶
• 喷
• 修补
• 软膏和香膏
• 其他（滚涂型）

6. 全球局部止痛药市场（依治疗应用），2020 年至 2032 年

• 下背部疼痛
• 肌肉疼痛
• 颈部疼痛
• 骨关节炎
• 偏头痛
• 头痛和丛集性头痛
• 足底筋膜炎
• 坐骨神经痛
• 黏液囊炎
• 慢性肌筋膜疼痛
• 肋软骨炎
• 急性味觉障碍
• 神经线病变
• 椎间滑脱
• 颞颚关节障碍症
• 肌腱炎
• 牙痛
• 糖尿病週边神经病变
• 类风湿性关节炎
• 发炎性疾病
• 其他（术后疼痛等）

7. 2020 年至 2032 年全球局部止痛药市场（依疼痛类型）

• 急性
• 慢性的

8. 全球局部止痛药市场分布，2020-2032

• 非处方药
• 处方笺

9. 2020 年至 2032 年全球局部止痛药市场（以药物类型）

• 原厂产品
• 非专利的

10. 2020-2032 年全球局部止痛药市场（以药物剂型）

• 单一代理
• 组合药物

11. 2020-2032 年全球局部止痛药市场（依性别）

• 男性
• 女士

12. 2020 年至 2032 年按年龄分類的全球局部止痛药市场

• 成人
• 孩子们
• 老年人

13. 全球局部止痛药市场依通路划分，2020-2032 年

• 医院药房
• 零售药局
• 网路药局

14. 2020 年至 2032 年全球局部止痛药市场（按地区）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十五章竞争格局

• Johnson & Johnson
• GlaxoSmithKline plc（Haleon）
• Sanofi
• Reckitt Benckiser Group plc
• Hisamitsu Pharmaceutical Co., Inc.
• Perrigo Company plc
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Boehringer Ingelheim International GmbH
• Endo International plc
• Topical BioMedics, Inc.
• The Mentholatum Company
• Pernix Therapeutics
• Hikma Pharmaceuticals PLC

第 16 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十七章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Topical Analgesic Market is estimated to be valued at USD 12.10 Bn in 2025 and is expected to reach USD 18.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

The global topical analgesic market represents a critical segment within the broader pain management pharmaceutical industry, encompassing a diverse range of externally applied therapeutic products designed to provide localized relief from various pain conditions. Topical analgesics, including creams, gels, patches, sprays, and ointments, deliver active pharmaceutical ingredients directly to affected areas through transdermal absorption, offering targeted pain relief while minimizing systemic exposure and associated side effects. This market serves multiple therapeutic applications, addressing acute and chronic pain conditions such as arthritis, muscle strains, back pain, neuropathic pain, and sports-related injuries. The increasing prevalence of musculoskeletal disorders, aging demographics, and growing consumer preference for non-invasive pain management alternatives have significantly contributed to market expansion. Key active ingredients driving market growth include menthol, capsaicin, salicylates, NSAIDs, and lidocaine, each offering distinct mechanisms of action for pain relief. The market encompasses both prescription and over-the-counter formulations, catering to diverse consumer needs and healthcare provider preferences. Technological advancements in drug delivery systems, including transdermal patches and nano-formulations, have enhanced product efficacy and patient compliance, further stimulating market development and creating opportunities for innovative therapeutic solutions.

Market Dynamics

The global topical analgesic market is primarily driven by several interconnected factors that collectively fuel sustained growth and market expansion. The increasing geriatric population worldwide, coupled with rising prevalence of chronic pain conditions such as arthritis, fibromyalgia, and neuropathic pain, creates substantial demand for effective topical pain management solutions. Growing awareness about the adverse effects of oral analgesics, including gastrointestinal complications and dependency risks, has shifted consumer and healthcare provider preferences toward topical alternatives that offer localized relief with reduced systemic exposure. The expanding sports and fitness culture, accompanied by increased participation in physical activities, generates consistent demand for topical analgesics addressing sports-related injuries and muscle fatigue. However, the market faces significant restraints that could impede growth trajectory. Stringent regulatory requirements for new product approvals, particularly for prescription formulations, create barriers to market entry and increase development costs for pharmaceutical companies. Limited penetration depth of topical formulations restricts their effectiveness for deep-seated pain conditions, potentially limiting market scope and consumer adoption. Price sensitivity among consumers, especially in emerging markets, poses challenges for premium-priced innovative products. Nevertheless, substantial opportunities exist within the market landscape. The development of advanced drug delivery technologies, including nanotechnology-based formulations and enhanced permeation systems, presents opportunities for improved therapeutic efficacy and expanded applications. Growing demand for natural and organic pain relief products creates niches for botanical-based formulations and clean-label alternatives. Emerging markets in Asia-Pacific and Latin America offer significant growth potential due to increasing healthcare spending, rising awareness about pain management, and expanding middle-class populations with greater purchasing power.

Key Features of the Study

• This report provides an in-depth analysis of the global topical analgesic market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global topical analgesic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Novartis AG, Sanofi, Reckitt Benckiser, Teva Pharmaceutical Industries, Mylan N.V., Hisamitsu Pharmaceutical, and The Mentholatum Company.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global topical analgesic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical analgesic market.

Market Segmentation

• Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
  • Non-Opioid Topical Analgesics
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Diclofenac
  • Ibuprofen
  • Ketoprofen
  • Piroxicam
  • Capsaicin-Based Analgesics
  • Methyl Salicylate (Salicylates)
  • Lidocaine and Local Anesthetics
  • CGRP Inhibitors
  • Other Non-Opioid Agents
  • Opioid-Based Topical Analgesics
• Formulation Insights (Revenue, USD Bn, 2020 - 2032)
  • Creams
  • Gels
  • Sprays
  • Patches
  • Ointments & Balms
  • Others (Roll-Ons)
• Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Back Pain
  • Muscle Pain
  • Neck Pain
  • Osteoarthritis
  • Migraine
  • Headache and Cluster Headaches
  • Plantar Fasciitis
  • Sciatica
  • Bursitis
  • Chronic Myofascial Pain
  • Costochondritis
  • Gout, Acute
  • Radiculopathy
  • Spondylolisthesis
  • Temporomandibular Joint Disorder
  • Tendonitis
  • Toothache
  • Diabetic Peripheral Neuropathy
  • Rheumatoid Arthritis
  • Inflammatory Conditions
  • Others (Postoperative Pain, etc.)
• Pain Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Acute
  • Chronic
• Distribution Insights (Revenue, USD Bn, 2020 - 2032)
  • Over-the-Counter (OTC)
  • Prescription-Based
• Drug Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Brand
  • Generic
• Drug Composition Insights (Revenue, USD Bn, 2020 - 2032)
  • Single
  • Combination
• Male Insights (Revenue, USD Bn, 2020 - 2032)
  • Male
  • Female
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Adult
  • Pediatric
  • Geriatric
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals Pharmacy
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Johnson & Johnson
  • GlaxoSmithKline plc (Haleon)
  • Sanofi
  • Reckitt Benckiser Group plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Perrigo Company plc
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Boehringer Ingelheim International GmbH
  • Endo International plc
  • Topical BioMedics, Inc.
  • The Mentholatum Company
  • Pernix Therapeutics
  • Hikma Pharmaceuticals PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Topical Analgesic Market, By Drug Class
  • Global Topical Analgesic Market, By Formulation
  • Global Topical Analgesic Market, By Therapeutic Application
  • Global Topical Analgesic Market, By Pain Type
  • Global Topical Analgesic Market, By Distribution
  • Global Topical Analgesic Market, By Drug Type
  • Global Topical Analgesic Market, By Drug Composition
  • Global Topical Analgesic Market, By Gender
  • Global Topical Analgesic Market, By Age Group
  • Global Topical Analgesic Market, By Distribution Channel
  • Global Topical Analgesic Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Topical Analgesic Market, By Drug Class, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Non-Opioid Topical Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      • Diclofenac
      • Ibuprofen
      • Ketoprofen
      • Piroxicam
    • Capsaicin-Based Analgesics
    • Methyl Salicylate (Salicylates)
    • Lidocaine and Local Anesthetics
    • CGRP Inhibitors
    • Other Non-Opioid Agents
• Opioid-Based Topical Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Topical Analgesic Market, By Formulation, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Creams
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sprays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ointments & Balms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Roll-Ons)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Topical Analgesic Market, By Therapeutic Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Back Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Muscle Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neck Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Osteoarthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Migraine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Headache and Cluster Headaches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Plantar Fasciitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sciatica
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bursitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Myofascial Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Costochondritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gout, Acute
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Radiculopathy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Spondylolisthesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Temporomandibular Joint Disorder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tendonitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Toothache
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetic Peripheral Neuropathy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rheumatoid Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Conditions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Postoperative Pain, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Topical Analgesic Market, By Pain Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Acute
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Topical Analgesic Market, By Distribution, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Over-the-Counter (OTC)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prescription-Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Topical Analgesic Market, By Drug Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Brand
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Generic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Topical Analgesic Market, By Drug Composition, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Combination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Topical Analgesic Market, By Gender, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Topical Analgesic Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Topical Analgesic Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

14. Global Topical Analgesic Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

15. Competitive Landscape

• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline plc (Haleon)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Reckitt Benckiser Group plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hisamitsu Pharmaceutical Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Perrigo Company plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Viatris Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boehringer Ingelheim International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Endo International plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Topical BioMedics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• The Mentholatum Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pernix Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hikma Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

16. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

17. References and Research Methodology

• References
• Research Methodology
• About us